Suppr超能文献

在肥胖受试者饮食限制期间,给予生长激素可保留瘦体重。

Growth hormone administration conserves lean body mass during dietary restriction in obese subjects.

作者信息

Clemmons D R, Snyder D K, Williams R, Underwood L E

出版信息

J Clin Endocrinol Metab. 1987 May;64(5):878-83. doi: 10.1210/jcem-64-5-878.

Abstract

Because weight-reducing diets result in loss of lean body tissue as well as fat, we sought to determine whether injections of GH might facilitate the preservation of nitrogen and accelerate the loss of body fat during dietary restriction. The dietary intake of 8 obese subjects was restricted to 24 Cal/kg ideal BW and 1 g protein/kg for 11 weeks. During weeks 3-5, 4 subjects were given a total of 10 im injections of recombinant methionyl human GH, 1 morning injection every 48 h in a dosage of 0.1 mg/kg ideal BW. The other 4 subjects were given injections of vehicle. During weeks 8-10, the subjects who had received GH previously were given vehicle and vice versa. While receiving GH injections the mean daily nitrogen deficit [0.35 +/- 2.14 (+/- SD) g/day] was significantly less than the loss during injection of vehicle (2.21 +/- 1.45 g/day; P less than 0.001). Although three of six subjects lost 190% more fat (as determined by hydrostatic weighing) while receiving GH, the difference in group mean fat loss during GH injection was not significantly greater than that during injection of vehicle (3.06 +/- 1.39 kg lost with GH vs. 2.64 +/- 1.08 kg lost with vehicle; P = NS). In parallel with the changes in nitrogen balance, GH produced a significant increase in the mean plasma somatomedin-C/insulin-like growth factor I concentration. From a mean pretreatment value of 1.06 +/- 0.28 U/mL, a maximal value of 3.20 +/- 1.60 U/mL was achieved after 12 days of GH injection (P less than 0.001). Somatomedin-C/insulin-like growth factor I concentrations did not change during injection of vehicle. During GH injection weight loss was attenuated because of fluid retention. If weight loss was determined 1 week after the end of GH administration, however, the total weight loss (3.42 +/- 1.73 kg) was not significantly different from that during the 3 weeks of vehicle administration and the following week (4.16 +/- 1.30 kg). Fasting blood glucose and serum insulin concentrations did not change during GH administration, and no glycosuria was detected in morning urine samples. Short term GH administration is effective in decreasing the loss of lean body mass in individuals ingesting restricted diets. However, fat loss was not accelerated.

摘要

由于减肥饮食会导致瘦体重和脂肪均减少,我们试图确定注射生长激素(GH)是否有助于在饮食限制期间保留氮并加速体脂流失。8名肥胖受试者的饮食摄入量在11周内限制为每千克理想体重24千卡热量和每千克1克蛋白质。在第3至5周期间,4名受试者共接受10次重组甲硫氨酰人GH的肌肉注射,每48小时在早晨注射一次,剂量为每千克理想体重0.1毫克。另外4名受试者注射赋形剂。在第8至10周期间,先前接受GH注射的受试者改为注射赋形剂,反之亦然。在接受GH注射期间,平均每日氮亏缺[0.35±2.14(±标准差)克/天]显著低于注射赋形剂期间的氮亏缺(2.21±1.45克/天;P<0.001)。尽管6名受试者中有3名在接受GH注射时脂肪减少量(通过水下称重测定)多出190%,但GH注射期间组平均脂肪减少量与注射赋形剂期间相比并无显著差异(接受GH注射时减少3.06±1.39千克,接受赋形剂注射时减少2.64±1.08千克;P=无显著差异)。与氮平衡的变化平行,GH使平均血浆生长调节素-C/胰岛素样生长因子I浓度显著升高。从注射前的平均1.06±0.28 U/mL,在注射GH 12天后达到最大值3.20±1.60 U/mL(P<0.001)。注射赋形剂期间生长调节素-C/胰岛素样生长因子I浓度未发生变化。在GH注射期间,由于液体潴留体重减轻有所减缓。然而,如果在GH给药结束后1周测定体重减轻情况,总体重减轻(3.42±1.73千克)与注射赋形剂的3周及随后1周期间的体重减轻(4.16±1.30千克)并无显著差异。在GH给药期间,空腹血糖和血清胰岛素浓度未发生变化,早晨尿液样本中未检测到糖尿。短期给予GH可有效减少摄入受限饮食个体的瘦体重损失。然而,脂肪减少并未加速。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验